Xingang Pharmaceutical
Xingang Pharmaceutical, also known as XG Pharmaceutical, is a prominent player in the global pharmaceutical industry, headquartered in China. Established in 2001, the company has made significant strides in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms, primarily serving markets in Asia, Europe, and North America. With a strong focus on research and development, Xingang Pharmaceutical offers a diverse portfolio of products, including generic medications and innovative formulations. Their commitment to quality and compliance with international standards has positioned them as a trusted partner in the pharmaceutical supply chain. Notable achievements include certifications from major regulatory bodies, underscoring their dedication to excellence in the industry.
DitchCarbon Score
How does Xingang Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Xingang Pharmaceutical's score of 15 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Xingang Pharmaceutical's reported carbon emissions
Xingang Pharmaceutical currently does not have publicly available carbon emissions data for recent years, nor are there specific reduction targets or initiatives outlined in their climate commitments. Without concrete figures or defined goals, it is challenging to assess their carbon footprint or climate strategy. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing greenhouse gas emissions, indicating a broader commitment to environmental responsibility. As the sector evolves, it is anticipated that companies like Xingang Pharmaceutical will adopt more transparent practices and set measurable targets to align with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Xingang Pharmaceutical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
